Журнал "Нирки" том 11, №1

Ïîãëÿä íà ïðîáëåìó / Looking at the Ðroblem
7. Luyckx V. еt al. Preventing CKD in Developed Countries. Kidney
International Reports. 2019. Vol. 5. Issue 3. Р. 263-277.
8. Ameh O. et al. Preventing CKD in Low- and Middle-Income
Countries: A Call for Urgent Action. Kidney International Reports.
2020. Vol. 5. Issue 3. Р. 255-262.
9. McCullough P.A. Anemia of cardiorenal syndrome. Kidney
International Supplements. 2021. 11(1). 35-45. doi: 10.1016/j.
kisu.2020.12.001.
10. Luyckx V.A., Smyth B., Harris D.C.H., Pecoits-Filho R.
Dialysis funding, eligibility, procurement, and protocols in low- and
middle-income settings: results from the International Society of Nephrology
collection survey. Kidney International Supplements. 2020.
10(1). e10-e18. doi: 10.1016/j.kisu.2019.11.005.
11. Klinger M., Madziarska K. Mortality predictor pattern in hemodialysis
and peritoneal dialysis in diabetic patients. Adv. Clin. Exp.
Med. 2019 Jan. 28(1). 133-135. doi: 10.17219/acem/76751. PMID:
30156388.
12. Sola L., Levin N.W., Johnson D.W., Pecoits-Filho R., Aljubori
H.M., Chen Y. et al. Development of a framework for minimum
and optimal safety and quality standards for hemodialysis and peritoneal
dialysis. Kidney International Supplements. 2020. 10(1). e55-
e62. doi: 10.1016/j.kisu.2019.11.009.
13. Saran R., Robinson B., Abbott K.C., Agodoa L.Y., Albertus
P., Ayanian J. et al. US renal data system 2016 annual data report:
epidemiology of kidney disease in the United States. American journal
of kidney diseases. 2017. 69(3). A7-A8.
14. Javaid M.M., Khan B.A., Subramanian S. Peritoneal dialysis
as initial dialysis modality: a viable option for late-presenting endstage
renal disease. J Nephrol. 2019 Feb. 32(1). 51-56. doi: 10.1007/
s40620-018-0485-3. Epub 2018 Apr 3. PMID: 29616470.
15. Wilkie M., Davies S. Peritoneal Dialysis in the time of
COVID-19. Peritoneal Dialysis International: Journal of the International
Society for Peritoneal Dialysis. 2020. 089686082092165. doi:
10.1177/0896860820921657.
16. Chuasuwan A., Pooripussarakul S., Thakkinstian A., Ingsathit
A., Pattanaprateep O. Comparisons of quality of life between
patients underwent peritoneal dialysis and hemodialysis: a systematic
review and meta-analysis. Health Qual Life Outcomes. 2020 Jun 18.
18(1). 191. doi: 10.1186/s12955-020-01449-2. PMID: 32552800;
PMCID: PMC7302145.
17. Swanepoel C.R., McCulloch M.I., Abraham G., Donner J.-A.,
Alrukhaimi M.N., Blake P.G. et al. Challenges for sustainable endstage
kidney disease care in low-middle-income countries: the problem
of the workforce. Kidney International Supplements. 2020. 10(1).
e49-e54. doi: 10.1016/j.kisu.2019.11.007.
18. O’Connell P.J., Brown M., Chan T.M., Claure-Del Granado
R., Davies S.J., Eiam-Ong S. et al. The role of kidney transplantation
as a component of integrated care for chronic kidney disease. Kidney
International Supplements. 2020. 10(1). e78-e85. doi: 10.1016/j.
kisu.2019.11.006.
19. Bello A.K., Okpechi I.G., Jha V., Harris D.C.H., Levin A.,
Johnson D.W. Global variation in kidney care: national and regional
differences in the care and management of patients with kidney failure.
Kidney International Supplements. 2021. 11(2) e1-e3. doi: 10.1016/j.
kisu.2020.11.003.
20. Hole B., Hemmelgarn B., Brown E., Brown M.,
McCulloch M.I., Zuniga C. et al. Supportive care for end-stage kidney
disease: an integral part of kidney services across a range of income
settings around the world. Kidney International Supplements. 2020.
10(1). e86-e94. doi:10.1016/j.kisu.2019.11.008.
21. Ivanov D.D., Mankovsky B.N. Antihypertensive treatment
and kidney function in routine practice in patients with type 2
diabetes mellitus: The results of the prospective “The Scythian” trial
in Ukraine. Open Urology and Nephrology Journal. 2014. 7(1).
71-76.
22. Ivanov D.D., Ivanova M.D., Crestanello T. Final results of
BIRCOV trial (ARB, ACEI, DRi in COVID-19). Kidneys. 2021. 10
(3). 143-149.
Отримано/Received 15.02.2022
Рецензовано/Revised 23.02.2022
Прийнято до друку/Accepted 10.04.2022
Information about author
Dmytro D. Ivanov, MD, Professor, Head of the Department of nephrology аnd renal replacement therapy, Shupyk National Healthcare University of Ukraine, Kyiv, Ukraine; https://orcid.org/0000-0003-
2609-0051
Conflicts of interests. Author declares the absence of any conflicts of interests and their own financial interest that might be construed to influence the results or interpretation of their manuscript.
D.D. Ivanov
Shupyk National Healthcare University of Ukraine, Kyiv, Ukraine
Kidney replacement therapy and global issues: world experience and our challenges
Abstract. The problem of renal replacement therapy (RRT)
is relevant in today’s world due to a large number of people with
chronic kidney disease (CKD). According to current data, abo ut
10–11 % of people suffer from CKD, of which up to 5 % need RRT.
Unfortunately, the number of people with CKD in the world is increasing,
which determines the growing need for RRT. There are
three types of RRT, namely: hemodialysis, peritoneal dialysis, and
kidney transplantation. Kidney transplantation is the most effective
method of RRT, but its possibilities in the world are limited.
Therefore, most people receive hemo- or peritoneal dialysis. But
the long-term effects of choosing a dialysis method are not always
predictable. The peritoneal dialysis and hemodialysis show similar
effectiveness during the first two years. Subsequent studies comparing
the efficacy of the two methods do not provide a clear picture
due to differences in patient initial parameters and differences in
treatment initiation time. It is clear that peritoneal dialysis can have
significant advantages in low-income countries due to the resource
costs of the latter. The known benefits of peritoneal dialysis, such as
flexibility of use, high quality of life, and preservation of residual renal
function, increase its attractiveness, especially for young people
with stage 5 CKD. The main strategies today are timely detection
and prevention of CKD, control of comorbidities, as well as the
development of documents and recommendations for standardization
and improving the quality of renal replacement therapy.
Keywords: renal replacement therapy; chronic kidney disease;
peritoneal dialysis; hemodialysis; quality of life
48 Íèðêè, ISSN 2307-1257 (print), ISSN 2307-1265 (online) Òîì 11, ¹ 1, 2022